Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 1, Pages e86843
Publisher
Public Library of Science (PLoS)
Online
2014-01-31
DOI
10.1371/journal.pone.0086843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo
- (2014) Lauren A. Gillory et al. Translational Oncology
- Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
- (2013) Lauren A. Gillory et al. PLoS One
- Predictors of survival and incidence of hepatoblastoma in the paediatric population
- (2013) Bassan J. Allan et al. HPB
- Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma
- (2012) Shu-Cheng Zhang et al. BMC CANCER
- FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma
- (2012) Michael L. Megison et al. CLINICAL & EXPERIMENTAL METASTASIS
- Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12
- (2012) J. M. Markert et al. JOURNAL OF VIROLOGY
- CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV
- (2012) Joseph G. Pressey et al. PEDIATRIC BLOOD & CANCER
- Children's Oncology Group's 2013 blueprint for research: Renal tumors
- (2012) Jeffrey S. Dome et al. PEDIATRIC BLOOD & CANCER
- Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma
- (2011) Elizabeth A. Beierle et al. CELL CYCLE
- α-Fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells
- (2011) M. Yamamoto et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1
- (2011) S J Advani et al. GENE THERAPY
- Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer
- (2011) Rafaela Argnani et al. LIVER INTERNATIONAL
- Pediatric Non-Wilms Renal Tumors: Subtypes, Survival, and Prognostic Indicators
- (2010) Ying Zhuge et al. JOURNAL OF SURGICAL RESEARCH
- Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program
- (2010) Christopher L. Morton et al. PEDIATRIC BLOOD & CANCER
- Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study group
- (2010) Marry M. van den Heuvel-Eibrink et al. PEDIATRIC BLOOD & CANCER
- Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111
- (2009) Gregory K. Friedman et al. JOURNAL OF NEURO-ONCOLOGY
- Modification and Reorganization of the Cytoprotective Cellular Chaperone Hsp27 during Herpes Simplex Virus Type 1 Infection
- (2009) S. S. Mathew et al. JOURNAL OF VIROLOGY
- Herpes Simplex Virus Oncolytic Therapy for Pediatric Malignancies
- (2009) Gregory K Friedman et al. MOLECULAR THERAPY
- Fetal and neonatal renal tumors
- (2008) Hart Isaacs JOURNAL OF PEDIATRIC SURGERY
- SK-NEP-1 and Rh1 are Ewing family tumor lines
- (2006) Malcolm A. Smith et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation